SECOND-LINE

作品数：43被引量：117H指数：6
导出分析报告
相关领域：医药卫生更多>>
相关机构：南京大学医学院附属鼓楼医院更多>>
相关期刊：《World Journal of Hepatology》《US-China Law Review》《Cancer Biology & Medicine》《Modern Chemotherapy》更多>>
相关基金：国家自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial
《Signal Transduction and Targeted Therapy》2024年第10期4590-4599,共10页Xiao Han Jun Guo Lingyu Li Yong Huang Xue Meng Linlin Wang Hui Zhu Xiangjiao Meng Qian Shao Xing Li Yan Zhang Jin Wang Yanhua Chen Yingjie Zhang Yiru Chen Changbin Zhu Zhehai Wang 
Natural Science Foundation of Shandong Province(ZR2023LSW024);Shandong medical and health science and technology development plan project(202103100568)。
Treatment options for patients with relapsed extensive-stage small cell lung cancer(ES-SCLC)remain scarce.This study aims to evaluate the efficacy and safety of combining anlotinib and sintilimab plus chemotherapy as ...
关键词：treatment phase FATIGUE 
Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic,gastrointestinal,and urinary bladder carcinomas:Recent concept
《World Journal of Hepatology》2024年第4期490-493,共4页Mohamed Wishahi 
Cancer immunotherapy is administered for first-line,second-line,neoadjuvant,or adjuvant treatment of advanced,metastatic,and recurrent cancer in the liver,gastrointestinal tract,and genitourinary tract,and other solid...
关键词：Programmed cell death protein-ligand 1 Erdafitinib Liver cancer Fibroblast growth factor receptor inhibitors Checkpoint inhibitors Bladder cancer Metastases 
IMpower210:A phase Ⅲ study of second-line atezolizumab vs. docetaxel in East Asian patients with non-small cell lung cancer
《Chinese Journal of Cancer Research》2024年第2期103-113,共11页Yi-Long Wu Shun Lu Gongyan Chen Jianxing He Jifeng Feng Yiping Zhang Liyan Jiang Hongming Pan Jianhua Chang Jian Fang Amy Cai Lilian Bu Jane Shi Jinjing Xia 
funded by F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd sponsored the IMpower210 study。
Objective: IMpower210(NCT02813785) explored the efficacy and safety of single-agent atezolizumab vs.docetaxel as second-line treatment for advanced non-small cell lung cancer(NSCLC) in East Asian patients.Methods: Key...
关键词：Atezolizumab East Asia non-small cell lung cancer programmed death-ligand 1 inhibitors monoclonal antibody 
Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase Ⅱ clinical trial
《Cancer Biology & Medicine》2023年第9期682-688,共7页Xiaoying Zhao Zhiyu Chen Xiaowei Zhang Xiaodong Zhu Wen Zhang Lixin Qiu Chenchen Wang Mingzhu Huang Zhe Zhang Wenhua Li Lei Yang Weijian Guo 
Objective:Paclitaxel(P)is a standard second-line chemotherapy in the treatment of advanced gastric cancer.This study compared the clinical outcome of a paclitaxel plus raltitrexed(RP)regimen as second-line treatment i...
关键词：Gastric adenocarcinoma RALTITREXED PACLITAXEL second-line palliative chemotherapy 
Third-line therapies in patients with Kawasaki disease refractory to first-and second-line intravenous immunoglobulin therapy
《World Journal of Pediatrics》2022年第11期781-785,共5页Takashi Furuta Hiroki Yasudo Seigo Okada Yuji Ohnishi Akiko Kawakami-Miyake Yasuo Suzuki Shouichi Ohga Shunji Hasegawa 
This work was supported in part by Japan Society for the Promotion of Science(JSPS)KAKENHI[Nos.16K19647(SY),19K08323(SH),and 21K15906(OS)]from the Ministry of Education,Culture,Sports,Science and Technology.
Kawasaki disease(KD)is an acute febrile ilness characterized by systemic vasculitis affecting the small-and mediumsized arteries in children [1,2].One of the most critical complications of KD is the development of cor...
关键词：INTRAVENOUS acute IMMUNOGLOBULIN 
Otological Injuries Observed in Head and Neck Trauma in a Second-Line Hospital
《International Journal of Otolaryngology and Head & Neck Surgery》2022年第3期119-125,共7页Ghislaine Neuilly Ngniée Tafo Koné Fatogoma Issa Samaké Djibril Timbo Samba Karim Keita Mohamed 
Otological injuries are common during cervicofacial trauma. The aim of this study is to describe the epidemiological characteristics and to map otological injuries during head and neck trauma. This was an observationa...
关键词：Otological Lesions TRAUMA SEQUELAE Hearing Loss DISABILITY 
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
《四川生理科学杂志》2021年第10期1805-1805,共1页Michael R Bishop 
Background:Patient outcomes are poor for aggressive B-cell non-Hodgkin's lymphomas not responding to or progressing within 12 months after first-line therapy.Tisagenlecleucel is an anti-CD19 chimeric antigen receptor ...
关键词：LYMPHOMA CHEMOTHERAPY allowed 
Real-world evidence on first-and second-line palliative chemotherapy in advanced pancreatic cancer被引量：1
《World Journal of Clinical Oncology》2021年第9期787-799,共13页Hakon Blomstrand Atul Batra Winson Y Cheung Nils Oskar Elander 
In spite of recent diagnostic and therapeutic advances,the prognosis of pancreatic ductal adenocarcinoma(PDAC)remains very poor.As most patients are not amenable to curative intent treatments,optimized palliative mana...
关键词：Pancreatic cancer Palliative therapy Cancer chemotherapy GEMCITABINE Paclitaxel nano albumin-bound Folfirinox 
Pancreatic adenocarcinoma:Beyond first line,where are we?被引量：1
《World Journal of Gastroenterology》2021年第17期1847-1863,共17页Sara Cherri Silvia Noventa Alberto Zaniboni 
Pancreatic cancer is considered one of the most aggressive cancers,with an increasing incidence in recent years.To date,chemotherapy is still the standard of care for advanced metastatic disease,unfortunately providin...
关键词：Pancreatic adenocarcinoma SECOND-LINE CHEMOTHERAPY Targeted therapy IMMUNOTHERAPY 
Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis:Is the evidence of sufficient quality to develop recommendations?被引量：8
《World Journal of Gastroenterology》2020年第38期5896-5910,共15页Mohammadreza Abdollahi Neda Khalilian Ekrami Morteza Ghojazadeh H Marike Boezen Mohammadhossein Somi Behrooz Z Alizadeh 
BACKGROUND The standard management of autoimmune hepatitis(AIH)is based on corticosteroids,alone or in combination with azathioprine.Second-line treatments are needed for patients who have refractory disease.However,h...
关键词：Autoimmune hepatitis Efficacy Grading of Recommendations Assessment Development and Evaluation approach Systematic review Meta-analysis SECOND-LINE 
全选清除导出
共5页<12345>
检索报告 对象比较 聚类工具 使用帮助 返回顶部